Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Empagliflozin (10mg) + Linagliptin (5mg)
Dosage Form : Tablet
Packaging Type : Blister
Packaging : 10*10
Price : ₹130/-
Emplozin L 10/5 Tablet is a combination therapy containing Empagliflozin (10mg) and Linagliptin (5mg), designed to provide effective management of type 2 diabetes mellitus. This combination works through complementary mechanisms to help control blood sugar levels and improve overall glycemic control in diabetic patients.
Together, these two drugs target different pathways to manage type 2 diabetes, providing a balanced and effective solution for maintaining blood sugar levels within a healthy range.
Common side effects may include nasopharyngitis, headache, urinary tract infections, and gastrointestinal disturbances. Serious side effects can include dehydration, hypotension, or kidney problems.
Emplozin L 10/5 Tablet is indicated for the management of type 2 diabetes mellitus to improve glycemic control, especially in patients who are unable to achieve adequate control through diet, exercise, and other medications alone.
Consult your doctor before using if you have a history of kidney problems or urinary tract infections. Do not use if pregnant or breastfeeding.
Store in a cool, dry place at room temperature (15°C-30°C), away from light and moisture.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation